Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DaDHS: Doxycycline for Syphilis Prevention
NCT02864550Phase 4Completed
- Sponsor
- British Columbia Centre for Disease Control
- Start
- Aug 2019
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in syphilis comparing Doxycycline Arm with Placebo Arm (2 arms). Primary endpoints: Proportion of participants who are eligible and consent to participate amongst those approached at 15 months, Proportion of participants reporting > 95% adherence to study drug at 15 months and 3 more. Started Aug 2019; status: completed.
02
Drugs
doxycycline
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT02864550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864550.